BAT Subsidiary Acquires Three More CHUC E-Cigarette Products in $1.5 Million Deal

Jul.07.2025
BAT Subsidiary Acquires Three More CHUC E-Cigarette Products in $1.5 Million Deal
Charlie’s Holdings has amended its deal with BAT’s R.J. Reynolds Vapor, selling three more PACHA synthetic nicotine e-cigarette products for $1.5 million. This brings BAT’s total acquisition to 15 CHUC products submitted for PMTA since April.

Key Points:

 

·The parties involved in the transaction are as follows: the seller is Charlie's Holdings, Inc. (CHUC); the buyer is R.J. Reynolds Vapor Company (a subsidiary of British American Tobacco).

 

·Transaction update: CHUC and R.J. Reynolds have revised their original asset purchase agreement; additional sale of 3 PACHA brand synthetic nicotine e-cigarette products and related assets.

 

·Transaction amount and payment method: the transaction amount for this transaction is $1.5 million; Disposable payment has been completed at the time of transaction delivery.

 

·Product compliance status: All three products have been submitted for PMTA (Pre-Market Tobacco Product Application) in 2022. They belong to the category of disposable e-cigarette products containing synthetic nicotine.

 

·Cumulative transaction overview: Prior to this, CHUC had already completed its first transaction on April 16, 2024, selling 12 similar products. Currently, R.J. Reynolds has acquired a total of 15 CHUC products.

 


【2Firsts news flash】According to a report from Charlie's Holdings, Inc. (OTC: CHUC), CHUC has reached a revised agreement with R.J. Reynolds Vapor Company, a subsidiary of British American Tobacco (BAT), for the purchase of existing assets. Under the new agreement, CHUC will sell three PACHA brand synthetic nicotine products and related assets to the buyer for $1.5 million, with payment made at the time of the transaction.

 

The report indicates that these three products were previously submitted for PMTA (Pre-Market Tobacco Product Application) by CHUC in 2022.

 

Previously, CHUC announced that it had reached and completed an asset sale transaction with R.J. Reynolds Vapor Company on April 16. According to the agreement, Charlie's sold to R.J. Reynolds its 12 PACHA disposable e-cigarette products that have submitted PMTA (premarket tobacco product application) along with their related assets, all of which use synthetic nicotine. According to a comparative analysis by 2Firsts, these products are part of the PACHA Syn 3000 series.

 

2Firsts has collected the parameter information of the PACHA syn 3000 series products, as shown in the table below:

 

解读|雷诺收购PMTA在审一次性电子烟:“水果+冰”口味及高浓度尼古丁为主 口数均为3000口
Pacha Syn 3000 Product Information | Design: 2Firsts

 

In terms of specifications, the Pacha Syn 3000 products all use synthetic nicotine with concentrations of 20mg and 50mg. In terms of appearance, the Pacha Syn 3000 features a cylindrical design and is equipped with a large capacity 1200mAh battery.

 

With the completion of this transaction, R.J. Reynolds Vapor Company has now acquired a total of 15 products under the CHUC brand.

 

雷诺烟草500万美元收购12款PMTA在审一次性电子烟 均为合成尼古丁产品
PACHA Brand Product Images | Image Source: PACHA Official Website

 

CHUC stated in its 8-K report filed with the U.S. Securities and Exchange Commission that the detailed text of this agreement has been included as Exhibit 10.1 in the filing and officially incorporated into the report.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
Tobacco Farming in the New Nicotine Era: Why Indian Farmers Struggle to Transition — Contributed by Samrat Chowdhery
In this contributed article to 2Firsts, Mumbai-based journalist and harm reduction advocate Samrat Chowdhery examines India’s tobacco transition from the perspective of agriculture, supply chains and regulation. As noted by 2Firsts, India offers a relevant case for understanding how new nicotine technologies may affect not only consumption, trade and policy, but also tobacco farming.
Special Report
May.29
UK Vaping Products Duty to Raise £565 Million by 2030/31
UK Vaping Products Duty to Raise £565 Million by 2030/31
The UK will introduce Vaping Products Duty on all vaping liquids from October 1, 2026, with government revenue forecast to rise from £135 million in 2026/27 to £565 million by 2030/31.
Jun.18
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
Dutch NVWA Seizes Record 277,000 Illegal Vapes; Video Shows “AL FAKHER” Cartons
Dutch NVWA Seizes Record 277,000 Illegal Vapes; Video Shows “AL FAKHER” Cartons
The Dutch Food and Consumer Product Safety Authority, known as the NVWA, seized more than 277,000 illegal vapes near Rotterdam and nearly 150,000 boxes of nicotine pouches in Utrecht and Rotterdam, calling them the largest batches of such products it has found to date. Video footage released by the NVWA shows some cartons in the warehouse bearing the “AL FAKHER / الفاخر” name, though the agency did not identify brands.
Jul.10
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01